Search results
Results from the WOW.Com Content Network
Fibrillin microfibrils are found in connective tissues, which mainly makes up fibrillin-1 [1] and provides elasticity. During the assembly, mirofibrils exhibit a repeating stringed-beads arrangement produced by the cross-linking of molecules forming a striated pattern with a given periodicity when viewed stained under an electron microscope.
It is believed that the microfibrils are composed of end-to-end polymers of fibrillin. To date, 3 forms of fibrillin have been described. The fibrillin-1 protein was isolated by Engvall in 1986, [5] and mutations in the FBN1 gene cause Marfan syndrome. [6] [7] This protein is found in humans, and its gene is found on chromosome 15.
Conventional vaccines contain either specific antigens from a pathogen, or attenuated viruses which stimulate an immune response in the vaccinated organism. DNA vaccines are members of the genetic vaccines, because they contain a genetic information (DNA or RNA) that codes for the cellular production (protein biosynthesis) of an antigen.
Cross-linking proteins determine filament orientation and spacing in the bundles and networks. These structures are regulated by many other classes of actin-binding proteins, including motor proteins, branching proteins, severing proteins, polymerization promoters, and capping proteins. [citation needed]
Fibrillin-1 is a protein that in humans is encoded by the FBN1 gene, located on chromosome 15. [5] [6] It is a large, extracellular matrix glycoprotein that serves as a structural component of 10–12 nm calcium-binding microfibrils. These microfibrils provide force bearing structural support in elastic and nonelastic connective tissue ...
A subunit vaccine is a vaccine that contains purified parts of the pathogen that are antigenic, or necessary to elicit a protective immune response. [1] [2] Subunit vaccine can be made from dissembled viral particles in cell culture or recombinant DNA expression, [3] in which case it is a recombinant subunit vaccine.
The mRNA vaccines made by Pfizer-BioNTech and Moderna were both designed within weeks of the release of the SARS-CoV-2 coronavirus genome, and first to come off manufacturing lines for worldwide use.
A genetic vaccine (also gene-based vaccine) is a vaccine that contains nucleic acids such as DNA or RNA that lead to protein biosynthesis of antigens within a cell. Genetic vaccines thus include DNA vaccines , RNA vaccines and viral vector vaccines .